Nagler, Arnon <br/><br/>
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.  [electronic resource] 

 -  Haematologica  Aug 2014 
 - 1380-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2014.105197  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Bone Marrow Transplantation--mortality<br/>Busulfan--administration & dosage<br/>Data Collection--methods<br/>Europe--epidemiology<br/>Female<br/>Hematopoietic Stem Cell Transplantation--mortality<br/>Humans<br/>Infusions, Intravenous<br/>Leukemia, Myeloid, Acute--mortality<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Survival Rate--trends<br/>Transplantation, Autologous--mortality<br/>Young Adult